113 related articles for article (PubMed ID: 14584658)
1. The relationship between expression of p53/bcl-2 and clinicopathological criteria in cervix squamous cell carcinomas.
Bitiren M; Cakmak EA; Gocmen A; Inaloz SS; Sari I; Karakok M; Aydin A
Eur J Gynaecol Oncol; 2003; 24(5):411-2. PubMed ID: 14584658
[TBL] [Abstract][Full Text] [Related]
2. The relationship between expression of p53/bcl-2 and clinicopathological criteria in endometrioid adenocarcinomas of the endometrium.
Sari I; Gocmen A; Bitiren M; Cakmak EA
Eur J Gynaecol Oncol; 2004; 25(1):79-80. PubMed ID: 15053067
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix.
Padovan P; Salmaso R; Marchetti M; Padovan R
Eur J Gynaecol Oncol; 2000; 21(3):267-72. PubMed ID: 10949392
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical analysis of sex-steroid receptors, tumor suppressor gene p53 and Ki-67 in the normal and neoplastic uterine cervix squamous epithelium.
Nikolaou M; Koumoundourou D; Ravazoula P; Papadopoulou M; Michail G; Decavalas G
Med Pregl; 2014; 67(7-8):202-7. PubMed ID: 25151759
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix.
Rajkumar T; Rajan S; Baruah RK; Majhi U; Selvaluxmi G; Vasanthan A
Eur J Gynaecol Oncol; 1998; 19(6):556-60. PubMed ID: 10215440
[TBL] [Abstract][Full Text] [Related]
6. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix.
Kanai M; Shiozawa T; Xin L; Nikaido T; Fujii S
Cancer; 1998 May; 82(9):1709-19. PubMed ID: 9576293
[TBL] [Abstract][Full Text] [Related]
8. [Aspects of Bcl-2 proto-oncogene expression in dysplastic and malignant lesions of the uterine cervix].
Borţun F; Chiovschi S; Moldovan M
Rev Med Chir Soc Med Nat Iasi; 2004; 108(4):821-6. PubMed ID: 16004225
[TBL] [Abstract][Full Text] [Related]
9. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].
Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III.
Fonseca-Moutinho JA; Cruz E; Carvalho L; Prazeres HJ; de Lacerda MM; da Silva DP; Mota F; de Oliveira CF
Int J Gynecol Cancer; 2004; 14(5):911-20. PubMed ID: 15361203
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
12. p53 and bcl-2 protein expression in non-small-cell lung carcinoma.
Athanassiadou P; Dosios T; Petrakakou E; Liossi A; Zerva C; Athanassiades P
Diagn Cytopathol; 1998 Oct; 19(4):255-9. PubMed ID: 9784987
[TBL] [Abstract][Full Text] [Related]
13. The relationship between expression of p53/Bcl-2 and histopathological criteria in breast invasive ductal carcinomas.
Gursan N; Karakök M; Sari I; Gursan MS
Int J Clin Pract; 2001 Nov; 55(9):589-90. PubMed ID: 11770353
[TBL] [Abstract][Full Text] [Related]
14. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.
Izawa H; Yonemitsu N; Shin T; Sugihara H
Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041
[TBL] [Abstract][Full Text] [Related]
15. Esophageal squamous cell carcinomas and expression of p53, Bcl-2, and Bcl-X(L).
Vlachos K; Siafakas N; Karameris A; Theodoropoulos G; Parassi E; Peros G; Papadopoulos J; Hakim N
Int Surg; 2008; 93(2):63-71. PubMed ID: 18998283
[TBL] [Abstract][Full Text] [Related]
16. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of p53 expression in stage IB1 cervical carcinoma.
Chen HY; Hsu CT; Lin WC; Tsai HD; Chang WC
Gynecol Obstet Invest; 2000; 49(4):266-71. PubMed ID: 10828711
[TBL] [Abstract][Full Text] [Related]
18. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: its relationship to clinical outcome.
Uehara T; Kuwashima Y; Izumo T; Kishi K; Shiromizu K; Matsuzawa M
Eur J Gynaecol Oncol; 1995; 16(6):453-60. PubMed ID: 8536760
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma.
Klatka J
Eur Arch Otorhinolaryngol; 2001 Dec; 258(10):537-41. PubMed ID: 11829192
[TBL] [Abstract][Full Text] [Related]
20. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
